 | • レポートコード：MRC23Q38201 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、67ページ • 納品方法：Eメール（2-3日） • 産業分類：医薬品 |
| Single User | ￥406,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥812,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のフィサラミン市場について調査・分析し、世界のフィサラミン市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（95%以上、98%以上）、用途別セグメント分析（科学研究、医学、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Peptide Institute、Vivitideなどが含まれています。世界のフィサラミン市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、フィサラミン市場規模を推定する際に考慮しました。本レポートは、フィサラミンの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、フィサラミンに関するビジネス上の意思決定に役立てることを目的としています。 ・フィサラミン市場の概要 - 製品の定義 - フィサラミンのタイプ別セグメント - 世界のフィサラミン市場規模：タイプ別分析（95%以上、98%以上） - フィサラミンの用途別セグメント - 世界のフィサラミン市場規模：用途別分析（科学研究、医学、その他） - 世界のフィサラミン市場規模予測（2018年-2029年） - フィサラミンの平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - フィサラミン市場の競争状況およびトレンド ・フィサラミンの地域別市場規模 - 北米のフィサラミン市場規模（2018年-2029年） - アメリカのフィサラミン市場規模（2018年-2029年） - ヨーロッパのフィサラミン市場規模（2018年-2029年） - アジア太平洋のフィサラミン市場規模（2018年-2029年） - 中国のフィサラミン市場規模（2018年-2029年） - 日本のフィサラミン市場規模（2018年-2029年） - 韓国のフィサラミン市場規模（2018年-2029年） - インドのフィサラミン市場規模（2018年-2029年） - オーストラリアのフィサラミン市場規模（2018年-2029年） - 中南米のフィサラミン市場規模（2018年-2029年） - 中東・アフリカのフィサラミン市場規模（2018年-2029年） ・タイプ別セグメント：95%以上、98%以上 - 世界のフィサラミンのタイプ別販売量（2018年-2023年） - 世界のフィサラミンのタイプ別売上（2018年-2023年） - 世界のフィサラミンのタイプ別価格 ・用途別セグメント：科学研究、医学、その他 - 世界のフィサラミンの用途別販売量（2018年-2023年） - 世界のフィサラミンの用途別売上（2018年-2023年） - 世界のフィサラミンの用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 Peptide Institute、Vivitide ・産業チェーンと販売チャネルの分析 - フィサラミン産業チェーン分析 - フィサラミンの主要原材料 - フィサラミンの販売チャネル - フィサラミンのディストリビューター - フィサラミンの主要顧客 ・フィサラミン市場ダイナミクス - フィサラミンの業界動向 - フィサラミン市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Highlights
The global Physalaemin market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Physalaemin is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Physalaemin is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Physalaemin include Peptide Institute and Vivitide etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Physalaemin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Physalaemin.
The Physalaemin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Physalaemin market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Physalaemin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Peptide Institute
Vivitide
Segment by Type
Above 95%
Above 98%
Segment by Application
Scientific Research
Medical
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Physalaemin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Physalaemin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Physalaemin Market Overview
1.1 Product Overview and Scope of Physalaemin
1.2 Physalaemin Segment by Type
1.2.1 Global Physalaemin Market Value Comparison by Type (2023-2029)
1.2.2 Above 95%
1.2.3 Above 98%
1.3 Physalaemin Segment by Application
1.3.1 Global Physalaemin Market Value by Application: (2023-2029)
1.3.2 Scientific Research
1.3.3 Medical
1.3.4 Others
1.4 Global Physalaemin Market Size Estimates and Forecasts
1.4.1 Global Physalaemin Revenue 2018-2029
1.4.2 Global Physalaemin Sales 2018-2029
1.4.3 Global Physalaemin Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Physalaemin Market Competition by Manufacturers
2.1 Global Physalaemin Sales Market Share by Manufacturers (2018-2023)
2.2 Global Physalaemin Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Physalaemin Average Price by Manufacturers (2018-2023)
2.4 Global Physalaemin Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Physalaemin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Physalaemin, Product Type & Application
2.7 Physalaemin Market Competitive Situation and Trends
2.7.1 Physalaemin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Physalaemin Players Market Share by Revenue
2.7.3 Global Physalaemin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Physalaemin Retrospective Market Scenario by Region
3.1 Global Physalaemin Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Physalaemin Global Physalaemin Sales by Region: 2018-2029
3.2.1 Global Physalaemin Sales by Region: 2018-2023
3.2.2 Global Physalaemin Sales by Region: 2024-2029
3.3 Global Physalaemin Global Physalaemin Revenue by Region: 2018-2029
3.3.1 Global Physalaemin Revenue by Region: 2018-2023
3.3.2 Global Physalaemin Revenue by Region: 2024-2029
3.4 North America Physalaemin Market Facts & Figures by Country
3.4.1 North America Physalaemin Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Physalaemin Sales by Country (2018-2029)
3.4.3 North America Physalaemin Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Physalaemin Market Facts & Figures by Country
3.5.1 Europe Physalaemin Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Physalaemin Sales by Country (2018-2029)
3.5.3 Europe Physalaemin Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Physalaemin Market Facts & Figures by Country
3.6.1 Asia Pacific Physalaemin Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Physalaemin Sales by Country (2018-2029)
3.6.3 Asia Pacific Physalaemin Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Physalaemin Market Facts & Figures by Country
3.7.1 Latin America Physalaemin Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Physalaemin Sales by Country (2018-2029)
3.7.3 Latin America Physalaemin Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Physalaemin Market Facts & Figures by Country
3.8.1 Middle East and Africa Physalaemin Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Physalaemin Sales by Country (2018-2029)
3.8.3 Middle East and Africa Physalaemin Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Physalaemin Sales by Type (2018-2029)
4.1.1 Global Physalaemin Sales by Type (2018-2023)
4.1.2 Global Physalaemin Sales by Type (2024-2029)
4.1.3 Global Physalaemin Sales Market Share by Type (2018-2029)
4.2 Global Physalaemin Revenue by Type (2018-2029)
4.2.1 Global Physalaemin Revenue by Type (2018-2023)
4.2.2 Global Physalaemin Revenue by Type (2024-2029)
4.2.3 Global Physalaemin Revenue Market Share by Type (2018-2029)
4.3 Global Physalaemin Price by Type (2018-2029)
5 Segment by Application
5.1 Global Physalaemin Sales by Application (2018-2029)
5.1.1 Global Physalaemin Sales by Application (2018-2023)
5.1.2 Global Physalaemin Sales by Application (2024-2029)
5.1.3 Global Physalaemin Sales Market Share by Application (2018-2029)
5.2 Global Physalaemin Revenue by Application (2018-2029)
5.2.1 Global Physalaemin Revenue by Application (2018-2023)
5.2.2 Global Physalaemin Revenue by Application (2024-2029)
5.2.3 Global Physalaemin Revenue Market Share by Application (2018-2029)
5.3 Global Physalaemin Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Peptide Institute
6.1.1 Peptide Institute Corporation Information
6.1.2 Peptide Institute Description and Business Overview
6.1.3 Peptide Institute Physalaemin Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Peptide Institute Physalaemin Product Portfolio
6.1.5 Peptide Institute Recent Developments/Updates
6.2 Vivitide
6.2.1 Vivitide Corporation Information
6.2.2 Vivitide Description and Business Overview
6.2.3 Vivitide Physalaemin Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Vivitide Physalaemin Product Portfolio
6.2.5 Vivitide Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Physalaemin Industry Chain Analysis
7.2 Physalaemin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Physalaemin Production Mode & Process
7.4 Physalaemin Sales and Marketing
7.4.1 Physalaemin Sales Channels
7.4.2 Physalaemin Distributors
7.5 Physalaemin Customers
8 Physalaemin Market Dynamics
8.1 Physalaemin Industry Trends
8.2 Physalaemin Market Drivers
8.3 Physalaemin Market Challenges
8.4 Physalaemin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer